MSI2 upregulation might contribute to the maintenance of stem cell properties in MCL cells through the post-transcriptional upregulation of stemness-related genes and downregulation of apoptotic factors, providing them with self-renewal capabilities, higher cell survival and chemoresistance (Fig. 7). This evidence concerns the gene MSI2 and mantle cell lymphoma.